Purchase Order 75N91025P00459

Award Date 9/29/25
Potential Completion Date 3/28/27
Potential Value $233K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), to Schrodinger LLC, a subsidiary of Schrodinger, Inc. The contract is for $683,974.00 and has an ultimate completion date of August 31, 2026. The purpose of the contract is to provide the NCI with molecular modeling software used to design therapeutics against HIV, various cancers, SARS-CoV-2, and other targets of interest to NIH...
This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS), to Schrodinger LLC. The $24,000.00 contract is for the provision of software products to support membrane protein modeling and simulation efforts. The award does not have a set-aside designation. Schrodinger LLC, a division of Schrodinger, Inc., is a leading provider of computational chemistry and molecular biophysics...
The Department of Health and Human Services, National Institutes of Health, National Center for Advancing Translational Sciences awarded a $198,220.00 firm fixed-price purchase order to Schrodinger LLC for the renewal of a license for Schrodinger's drug discovery software. The software supports drug review, research efforts, and computational capabilities for various federal agencies. Schrodinger LLC is a division of Schrodinger, Inc., a scientific leader in developing chemical simulation...
This is a firm-fixed-price purchase order awarded by a civilian federal agency, the Northeast Area of an unspecified agency, to Schrodinger LLC, a division of Schrodinger, Inc. The $8,199 contract is for the provision of Schrodinger's specialized chemical simulation software, including the Small Molecule Drug Discovery Suite, Schrodinger Suite, LiveDesign, Comptox, and Materials Science Suite. These software products are used to support drug review, research efforts, and computational...
This contract award is for the renewal of a Molecular Modeling License from Schrödinger LLC, a division of Schrödinger, Inc., to the National Institute of Environmental Health Sciences (NIEHS), which is part of the Department of Health and Human Services (HHS) National Institutes of Health (NIH). The contract is a Firm Fixed Price Purchase Order with a potential value of $125,375.00 and a completion date of June 30, 2019. Schrödinger LLC has been awarded over 20 similar federal contracts from...
This is a $40,000.00 firm-fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services (HHS), to Schrodinger LLC, a division of Schrodinger, Inc. The contract has no set-aside designation. Schrodinger LLC is a leading provider of state-of-the-art chemical simulation software for pharmaceutical, biotechnology, and materials research applications. Under this contract, Schrodinger LLC will...
This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Schrodinger LLC, a division of Schrodinger, Inc. The contract is for a Schrodinger Suite software license with maintenance and support, with a ceiling value of $288,254. The contract has an ultimate completion date of June 27, 2028. Schrodinger LLC is a leading provider of advanced computational tools for drug discovery and materials science, primarily serving government agencies within the...
The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences (HHS/NIH/NIEHS) awarded Schrodinger LLC a $149,600.00 firm-fixed-price purchase order to renew Schrodinger software licenses. The contract has a completion date of June 30, 2018 and was awarded on June 29, 2017. Schrodinger LLC is a division of Schrodinger, Inc., a leading provider of chemical simulation software for pharmaceutical, biotechnology, and materials...
This federal contract award was made by an unspecified U.S. government agency to Schrodinger, Inc., a for-profit organization that develops chemical simulation software for the pharmaceutical, biotechnology, and materials research industries. The $128,335.00 firm-fixed-price purchase order provides Schrodinger with 11-month floating software licenses for its MACROMODEL, GLIDE, and related software modules. The contract does not have a set-aside designation. Schrodinger is an experienced...
This is a $192,110.00 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Schrodinger LLC for an annual subscription to Schrodinger's Small Molecule Drug Discovery Suite software. The award was made on a sole-source, non-competitive basis without a set-aside. Schrodinger LLC is a for-profit limited liability company that provides computational drug design solutions to the...

This is a firm fixed-price purchase order awarded by the National Cancer Institute, an agency within the U.S. Department of Health and Human Services, to Schrodinger LLC for the provision of Schrodinger molecular modeling software. The contract has a ceiling value of $232,500.00 and a period of performance ending on March 28, 2027. Schrodinger LLC is a leading provider of advanced chemical simulation software for pharmaceutical, biotechnology, and materials research applications. The company has received numerous federal contract awards, primarily from civilian agencies within HHS, to supply software licenses and related services in support of drug review, research efforts, and computational capabilities across the government. This contract does not utilize a set-aside designation.

Generated 9/30/25, 9:52 AM